Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-14

Clinical Trial Update: Vortioxetine Adjunctive Treatment in Bipolar Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on vortioxetine as adjunctive treatment for bipolar depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vortioxetine (vortioxetine)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Bipolar Depression | Phase 4 | Status: COMPLETED